Wave Life Sciences, Inc.

WVE

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001631574

SEC filings (opens in a new tab)

In the last 90 days, Wave Life Sciences, Inc. insiders filed 0 open-market purchases and 4 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.

Q3 2022 vs. Q2 2022

How the institutions holding Wave Life Sciences, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022 All holders in Q2 2022

13F holders of WVE: Q2 2022 compared with Q3 2022
Measure	Q2 2022	Q3 2022	Change
Holders	60	61	+1
Shares	67.8M	67.3M	−527.9K (−0.8%)
Value	$220.3M	$242.8M	+$22.5M (+10.2%)

New holders (10)

Institutions that held Wave Life Sciences, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to WVE in Q3 2022
Institution	Shares	Value	% of portfolio
Point72 Asset Management, L.P.	1,034,200	$3.73M	0.02%
Woodline Partners LP	487,214	$1.76M	0.03%
Walleye Capital LLC	401,500	$1.45M	0.03%
Two Sigma Investments, LP	63,666	$230.0K	0.00%
Susquehanna International Group, LLP	35,476	$128.0K	0.00%
Group One Trading, L.P.	30,316	$109.0K	0.00%
Chicago Partners Investment Group LLC	23,009	$101.0K	0.01%
Caxton Associates LP	24,013	$87.0K	0.01%
Barclays PLC	3,731	$13.0K	0.00%
China Universal Asset Management Co., Ltd.	813	$3.00K	0.00%

Sold out (9)

Institutions that held Wave Life Sciences, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of WVE in Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
DAFNA Capital Management LLC	372,361	$1.21M
Ikarian Capital, LLC	98,039	$318.0K
Panagora Asset Management Inc	65,543	$213.0K
Boothbay Fund Management, LLC	27,932	$91.0K
Prudential Financial Inc	12,600	$41.0K
Y-Intercept (Hong Kong) Ltd	11,295	$37.0K
High Net Worth Advisory Group LLC	1,000	$3.00K
New York State Common Retirement Fund	353	$1.00K
Credit Suisse AG	24	$0